View abstract

This abstract is assigned to session BRS – Retina Update 2022

Presentation type	Invited
Title	Breaking news 2022 : Faricimab pivotal trial 2 year results, HD-Aflibercept first results

Authors 1

Last name	DIRVEN
Initials	W